Africa’s role in global health innovation is entering a new phase defined by stronger institutions, deeper scientific capacity, and coordinated regulatory leadership.

ACHIEVE Africa (Advancing Capacity for Health Innovation, Equity, and Vaccine Ecosystems in Africa) initiative reflects this shift, and regulatory capacity is among its key pillars. Strong regulatory systems are essential to ensuring that vaccines and biologics developed and manufactured in Africa meet the highest standards for safety, quality, and efficacy.

“Sustainable vaccine and biologics manufacturing depends not only on scientific and production capacity, but also on robust regulatory systems that inspire global confidence,” said Eric Karikari-Boateng, Head of Global Regulatory Strategy at Bio Usawa.

Organizations like Bio Usawa exemplify this shift, translating Africa’s expanding scientific expertise into scalable, GMP-aligned solutions that strengthen health security and regional resilience.